Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway

[1]  D. Carson,et al.  PPARγ Modulation of Cytokine‐Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer‐Derived Cells , 2017, Journal of cellular biochemistry.

[2]  C. Rancourt,et al.  CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling , 2016, Molecular Cancer.

[3]  Pamela E. Constantinou,et al.  Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB , 2016, Oncotarget.

[4]  A. Piché.  Pathobiological role of MUC16 mucin (CA125) in ovarian cancer: Much more than a tumor biomarker , 2016 .

[5]  R. Broaddus,et al.  Cytokine Stimulation of MUC4 Expression in Human Female Reproductive Tissue Carcinoma Cell Lines and Endometrial Cancer , 2015, Journal of cellular biochemistry.

[6]  Guy Boivin,et al.  Optimization of Droplet Digital PCR from RNA and DNA extracts with direct comparison to RT-qPCR: Clinical implications for quantification of Oseltamivir-resistant subpopulations. , 2015, Journal of virological methods.

[7]  C. Rancourt,et al.  Ovarian cancer ascites enhance the migration of patient‐derived peritoneal mesothelial cells via cMet pathway through HGF‐dependent and ‐independent mechanisms , 2015, International journal of cancer.

[8]  C. Rancourt,et al.  Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers , 2015, BMC Cancer.

[9]  S. Batra,et al.  Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments , 2015, Scientific Reports.

[10]  Lynette M. Smith,et al.  Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells , 2015, Oncotarget.

[11]  C. Rancourt,et al.  Transformation of NIH3T3 mouse fibroblast cells by MUC16 mucin (CA125) is driven by its cytoplasmic tail. , 2015, International journal of oncology.

[12]  J. Gonzalez-Bosquet,et al.  MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress , 2014, Molecular Cancer.

[13]  C. Rancourt,et al.  MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression , 2014, BMC Cancer.

[14]  C. Rancourt,et al.  MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression , 2014, BMC Cancer.

[15]  R. Krediet.  Cancer Antigen 125 As a Biomarker in Peritoneal Dialysis: Mesothelial Cell Health or Death? , 2013, Peritoneal Dialysis International.

[16]  H. Nakada,et al.  CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion. , 2013, European journal of cell biology.

[17]  J. Bargman.  Re: Cancer Antigen 125 As a Biomarker in Peritoneal Dialysis: Mesothelial Cell Health or Death? , 2013, Peritoneal Dialysis International.

[18]  J. Bargman,et al.  Cancer Antigen 125 as a Biomarker in Peritoneal Dialysis: Mesothelial Cell Health or Death? , 2013, Peritoneal Dialysis International.

[19]  S. Reinartz,et al.  CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells. , 2012, European journal of cancer.

[20]  I. Gipson,et al.  A Metalloproteinase Secreted by Streptococcus pneumoniae Removes Membrane Mucin MUC16 from the Epithelial Glycocalyx Barrier , 2012, PloS one.

[21]  S. Batra,et al.  MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells , 2012, Oncogene.

[22]  C. Rancourt,et al.  Profiling of cytokines in human epithelial ovarian cancer ascites. , 2012, American journal of cancer research.

[23]  S. Batra,et al.  Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades , 2012, Molecular Cancer.

[24]  Maxime Pinard,et al.  MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. , 2011, Gynecologic oncology.

[25]  C. Rancourt,et al.  Ovarian cancer ascites protects from TRAIL-induced cell death through αvβ5 integrin-mediated focal adhesion kinase and Akt activation , 2010, Oncogene.

[26]  I. Gipson,et al.  Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. , 2010, Experimental eye research.

[27]  C. Rancourt,et al.  CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. , 2009, Gynecologic oncology.

[28]  D. Kufe,et al.  Mucins in cancer: function, prognosis and therapy , 2009, Nature Reviews Cancer.

[29]  R. Bristow,et al.  Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. , 2009, Anticancer research.

[30]  K. Tsubota,et al.  Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis , 2008, Allergy.

[31]  S. Peiró,et al.  IL-6 induces MUC4 expression through gp130/STAT3 pathway in gastric cancer cell lines. , 2008, Biochimica et biophysica acta.

[32]  I. Gipson,et al.  Release of membrane-associated mucins from ocular surface epithelia. , 2008, Investigative ophthalmology & visual science.

[33]  S. Sel,et al.  Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines. , 2008, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[34]  C. Rancourt,et al.  Malignant ascites protect against TRAIL‐induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells , 2007, International journal of cancer.

[35]  A. Yang,et al.  Leptin augments myofibroblastic conversion and fibrogenic activity of human peritoneal mesothelial cells: a functional implication for peritoneal fibrosis. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  D. Thornton,et al.  MUC16 is produced in tracheal surface epithelium and submucosal glands and is present in secretions from normal human airway and cultured bronchial epithelial cells. , 2007, The international journal of biochemistry & cell biology.

[37]  A. Thathiah,et al.  Tumor Necrosis Factor α Stimulates MUC1 Synthesis and Ectodomain Release in a Human Uterine Epithelial Cell Line , 2004 .

[38]  I. Gipson,et al.  MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. , 2003, Investigative ophthalmology & visual science.

[39]  K. Shigemasa,et al.  The CA 125 Gene: A Newly Discovered Extension of the Glycosylated N-Terminal Domain Doubles the Size of This Extracellular Superstructure , 2002, Tumor Biology.

[40]  B. Yin,et al.  Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene , 2002, International journal of cancer.

[41]  T. O'brien,et al.  The CA 125 Gene: An Extracellular Superstructure Dominated by Repeat Sequences , 2001, Tumor Biology.

[42]  B. Yin,et al.  Molecular Cloning of the CA125 Ovarian Cancer Antigen , 2001, The Journal of Biological Chemistry.

[43]  M. Nap.  Immunohistochemistry of CA 125 , 1998, The International journal of biological markers.

[44]  O. Dapunt,et al.  Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. , 1996, Gynecologic oncology.

[45]  V. Abeler,et al.  Evaluation of serum CA 125 levels in the monitoring of ovarian cancer , 1987, American journal of obstetrics and gynecology.

[46]  P. Wilkinson,et al.  Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. , 1984, British Journal of Cancer.

[47]  R. Bast,et al.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.

[48]  R. Bast,et al.  Tissue Distribution of a Coelomic- Epithelium‐Related Antigen Recognized by the Monoclonal Antibody OC125 , 1983, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.